Request an appointmentat Mayo Clinic
Neuro-oncologist Dr. Wendy Sherman gives an overview of meningioma, glioblastoma and secondary brain tumors.
Researchers used a new immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors in mouse models.
Almost overnight Jeremy Paterno became one of the 240,000 people worldwide diagnosed with glioblastoma, the most common and aggressive type of brain cancer.
Despite improvements in median and short-term survival rates in glioblastoma, the percentage of patients achieving five-year survival remains low, according to new Mayo Clinic research.